Search Results 991-1000 of 18593 for Prednisone

1. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

   ... prednisone daily (or equivalent). Has any unresolved toxicity ≥ Grade 2 from previous anticancer therapy. Has history of brain metastases or spinal cord ...

2. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   - Active autoimmune disease requiring systemic immunosuppressive therapy (i.e. >10mg of prednisone daily or equivalent). - Participant, who in the opinion ...

3. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications ...

4. A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, And Elotuzumab, Pomalidomide, And Dexamethasone Or Pomalidomide, Bortezomib, And Dexamethasone In Participants With Relapsed Or Refractory Myeloma Who Have Received An Anti-CD38 Antibody And Lenalidomide - Mayo Clinic

   A maximum cumulative dose of corticosteroids of >=140 mg of prednisone or equivalent within 14-day period before the first dose of study drug. Known active ...

5. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   Patients must not be receiving concurrent steroids > 10 mg prednisone (or equivalent) per day; Prior irradiation is allowed if ≥ 28 days prior to ...

6. A Study Of PARG Inhibitor ETX-19477 In Patients With Advanced Solid Malignancies (ERADIC8) - Mayo Clinic

   Receiving continuous corticosteroids at prednisone-equivalent dose of >10 mg/day. Chronic systemic corticosteroid therapy for physiologic replacement (≤10 ...

7. Probenecid (oral route) - Side effects & dosage - Mayo Clinic

   Probenecid is used in the treatment of chronic gout or gouty arthritis. These conditions are caused by too much uric acid in the blood. The medicine works by ...

8. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

   Prednisone dose > 25 mg/day at any time in the previous 4 weeks. ≥ 20% fibrosis as indicated on CT-scan that has been confirmed by central read prior to ...

9. Publications - Blanca C. Lizaola-Mayo, M.D.

   Publications · Ohara SY, Aslam U, Lemond LM, Steidley DE, Sen A, Jayaraman AL, Jayasekera CR, Barnhill M, Lizaola-Mayo BC, Sell-Dottin KA, Nguyen MC, Mathur AK, ...

10. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    prednisone (> 10 mg), cyclophosphamide, tacrolimus, sirolimus, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents ...